Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07353892 · ClinicalTrials.gov registry record · NA
Robotic Exoskeletons in Acute Care Therapy
A NA study of Patients Post-cardiothoracic Surgery, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07353892 is a NA study of Patients Post-cardiothoracic Surgery that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07353892, a NA study of Patients Post-cardiothoracic Surgery, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to establish the safety, feasibility, and preliminary findings of overground robotic exoskeleton early ambulation (ORE-EA) compared to usual care early ambulation (UC-EA) in the rehabilitation of patients who have had cardiovascular or thoracic surgery. The main questions it aims to answer are: * Is there a difference between groups in time between surgery and ambulation? * Are there differences in safety and feasibility?
Conditions Studied
Interventions
- DEVICE Overground robotic exoskeleton early ambulation (ORE-EA)
- OTHER Usual care early ambulation (UC-EA)
Study Locations (1)
Texas
- Baylor Institute for Rehabilitation - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07353892
The ClinicalTrials.gov registry entry for NCT07353892 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patients Post-cardiothoracic Surgery appearing as the primary indexed condition, and to 2 interventions - of which Overground robotic exoskeleton early ambulation (ORE-EA) is the first listed.
NCT07353892 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07353892 about?
NCT07353892 is a clinical study titled "Robotic Exoskeletons in Acute Care Therapy". The goal of this clinical trial is to establish the safety, feasibility, and preliminary findings of overground robotic exoskeleton early ambulation (ORE-EA) compared to usual care early ambulation (UC-EA) in the rehabilitation of patients who have had cardiovascular or thoracic surgery. The main qu...
What is the current status of trial NCT07353892?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-02. Estimated completion is 2027-07-01.
What conditions does trial NCT07353892 study?
This clinical trial studies the following conditions: Patients Post-cardiothoracic Surgery.
What interventions are being tested in trial NCT07353892?
The interventions under investigation include: Overground robotic exoskeleton early ambulation (ORE-EA) (DEVICE), Usual care early ambulation (UC-EA) (OTHER).
Who is sponsoring clinical trial NCT07353892?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07353892 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.